Patents by Inventor Mark E. Schnute

Mark E. Schnute has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6562822
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: May 13, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventor: Mark E. Schnute
  • Patent number: 6559145
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: May 6, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Fred L. Ciske, Michael J. Genin, Byung Hyun Lee, Mark E. Schnute, Valerie A. Vaillancourt
  • Publication number: 20020188004
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: December 12, 2002
    Inventor: Mark E. Schnute
  • Publication number: 20020103220
    Abstract: The present invention provides compounds of formula I 1
    Type: Application
    Filed: June 5, 2001
    Publication date: August 1, 2002
    Inventor: Mark E. Schnute
  • Publication number: 20020025959
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 28, 2002
    Inventors: David John Anderson, Thomas J. Beauchamp, Gordon L. Bundy, Fred L. Ciske, John R. Farrell, David R. Graber, Michael J. Genin, Thomas M. Judge, Malcolm Wilson Moon, Mark E. Schnute, Joseph Walter Strohbach, Suvit Thaisrivongs, Atli Thorarensen, Steven Robert Turner, Valerie A. Vaillancourt, Allison J. Wolf
  • Publication number: 20020025960
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 28, 2002
    Inventors: Gordon L. Bundy, Fred L. Ciske, Michael J. Genin, Steven E. Heasley, Scott D. Larsen, Byung Hyun Lee, Paul D. May, John R. Palmer, Mark E. Schnute, Valerie A. Vaillancourt, Atli Thorarensen, Allison J. Wolf, Nancy Anne Wicnienski, David Wilhite
  • Publication number: 20020019397
    Abstract: The present invention provides a compound of formula I 1
    Type: Application
    Filed: June 22, 2001
    Publication date: February 14, 2002
    Applicant: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Valerie A. Vaillancourt, Scott D. Larsen
  • Publication number: 20020006937
    Abstract: The invention provides a compound of formula I: 1
    Type: Application
    Filed: April 2, 2001
    Publication date: January 17, 2002
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Mark E. Schnute, Michele M. Cudahy, Allen Scott
  • Patent number: 6248736
    Abstract: The present invention provides a compound of formula I Wherein R1 is C1-7 alkyl, optionally substituted by hydroxy or NR4R5; R2 is C1-7 alkyl substituted by hydroxy or NR4R5; R3 is H, F or C1-7 alkoxy; R4 and R5 together with N are a 5- or 6-membered heterocyclic moiety having 1-3 heteroatoms selected from the group consisting of nitrogen, oxygen and sulfur in which sulfur may be substituted by one (1) or two (2) oxygen atoms; and pharmaceutically acceptable salts thereof Compounds of formula I of the present invention are useful as antiviral agents.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: June 19, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Mark E. Schnute, Allen Scott
  • Patent number: 6248739
    Abstract: The present invention provides a compound of formula I which is useful as antiviral agents, in particular, as agents against viruses of the herpes family.
    Type: Grant
    Filed: December 17, 1999
    Date of Patent: June 19, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Steven Ronald Turner, Joseph Walter Strohbach, Suvit Thaisrivongs, Valerie A. Vaillancourt, Mark E. Schnute, John Alan Tucker
  • Patent number: 6239142
    Abstract: The invention provides a compound of formula I: wherein R1, R2, R3, and R4 have any of the values defined in the specification, or a pharmaceutically acceptable salt thereof, as well as processes and intermediates useful for preparing such compounds or salts, and methods of preventing or treating a herpesvirus infection using such compounds or salts.
    Type: Grant
    Filed: March 7, 2000
    Date of Patent: May 29, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Mark E. Schnute, Michele M. Cudahy, Allen Scott
  • Patent number: 6093732
    Abstract: The present invention provides 4-hydroxyquinoline-3-carboxamide and hydrazide compounds of formula I ##STR1## These compounds are useful to treat or prevent the herpesviral infections, particularly, human cytomegaloviral infection.
    Type: Grant
    Filed: December 1, 1998
    Date of Patent: July 25, 2000
    Assignee: Pharmacia & Upjohn Company
    Inventors: John Alan Tucker, Valerie A. Vaillancourt, Joseph Walter Strohbach, Karen Rene Romines, Mark E. Schnute, Michele M. Cudahy, Suvit Thaisrivongs, Steven Ronald Turner